Australia's most trusted
source of pharma news
">
Posted 16 April 2025 AM
Eli Lilly has used mainstream media to warn it could pull "tens of millions of dollars" invested in Australian clinical trials unless the Federal Government drastically slashes the time it takes to fund new medicines on the PBS.
In a high-profile news story published in the Australian Financial Review (AFR) yesterday, visiting Lilly executive, Ilya Yuffa, expressed clear exasperation with the current wait time of 466 days on average between TGA registration and reimbursement.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.